Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 3549375, 7 pages
https://doi.org/10.1155/2017/3549375
Research Article

A Role of the ABCC4 Gene Polymorphism in Airway Inflammation of Asthmatics

1Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Republic of Korea
2Department of Biomedical Sciences, Graduate School of Ajou University, Suwon, Republic of Korea
3Clinical Trial Center, Ajou University Medical Center, Suwon, Republic of Korea

Correspondence should be addressed to Hae-Sim Park and Seung-Hyun Kim

Received 14 March 2017; Accepted 10 April 2017; Published 4 June 2017

Academic Editor: Younghyo Kim

Copyright © 2017 Sailesh Palikhe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Borst, C. de Wolf, and K. van de Wetering, “Multidrug resistance-associated proteins 3, 4, and 5,” Pflügers Archiv, vol. 453, no. 5, pp. 661–673, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. S. L. Gelhaus, O. Gilad, W. T. Hwang, T. M. Penning, and I. A. Blair, “Multidrug resistance protein (MRP) 4 attenuates benzo[a]pyrene-mediated DNA-adduct formation in human bronchoalveolar H358 cells,” Toxicology Letters, vol. 209, no. 1, pp. 58–66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. P. Lin, Y. L. Zhu, D. R. Johnson et al., “Disruption of cAMP and prostaglandin E2 transport by multidrug resistance protein 4 deficiency alters cAMP-mediated signaling and nociceptive response,” Molecular Pharmacology, vol. 73, no. 1, pp. 243–251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. C. Rees, E. Johnson, and O. Lewinson, “ABC transporters: the power to change,” Nature Reviews. Molecular Cell Biology, vol. 10, no. 3, pp. 218–227, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Reid, P. Wielinga, N. Zelcer et al., “The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 16, pp. 9244–9249, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Zhao, Y. Guo, W. Yue, L. Zhang, M. Gu, and Y. Wang, “ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer,” Onco Targets Therapy, vol. 7, pp. 343–351, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. C. K. Billington, O. O. Ojo, R. B. Penn, and S. Ito, “cAMP regulation of airway smooth muscle function,” Pulmonary Pharmacology & Therapeutics, vol. 26, no. 1, pp. 112–120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Rius, J. Hummel-Eisenbeiss, and D. Keppler, “ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4),” The Journal of Pharmacology and Experimental Therapeutics, vol. 324, no. 1, pp. 86–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. M. Janciauskiene, I. M. Nita, and T. Stevens, “α1-Antitrypsin, old dog, new tricks. α1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP,” The Journal of Biological Chemistry, vol. 282, no. 12, pp. 8573–8582, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Wang and R. D. Klein, “Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway,” Molecular Carcinogenesis, vol. 46, no. 11, pp. 912–923, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. W. Steinke, J. Negri, S. C. Payne, and L. Borish, “Biological effects of leukotriene E_{4} on eosinophils,” Prostaglandins, Leukotrienes, and Essential Fatty Acids, vol. 91, no. 3, pp. 105–110, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Lee, T. H. Kim, F. Murray et al., “Cyclic AMP concentrations in dendritic cells induce and regulate Th2 immunity and allergic asthma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 5, pp. 1529–1534, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. R. van de Ven, G. L. Scheffer, A. W. Reurs et al., “A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration,” Blood, vol. 112, no. 6, pp. 2353–2359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Ulrych, A. Böhm, A. Polzin et al., “Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation,” Journal of Thrombosis and Haemostasis, vol. 9, no. 4, pp. 790–798, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Abla, L. W. Chinn, T. Nakamura et al., “The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene,” The Journal of Pharmacology and Experimental Therapeutics, vol. 325, no. 3, pp. 859–868, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Copsel, C. Garcia, F. Diez et al., “Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation,” The Journal of Biological Chemistry, vol. 286, no. 9, pp. 6979–6988, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. H. Kim, J. S. Bae, J. W. Holloway et al., “A polymorphism of MS4A2 (−109T>C) encoding the beta-chain of the high-affinity immunoglobulin E receptor (FcepsilonR1beta) is associated with a susceptibility to aspirin-intolerant asthma,” Clinical and Experimental Allergy, vol. 36, no. 7, pp. 877–883, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Y. Ban, K. Cho, S. H. Kim et al., “Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease,” Clinical and Experimental Allergy, vol. 47, no. 1, pp. 37–47, 2017. View at Publisher · View at Google Scholar
  19. M. A. Kim, M. K. Yoon, Y. S. Lee et al., “Clinical implication of the serum periostin level for differentiating phenotypes of NSAID hypersensitivity,” Allergology International, vol. 65, no. 4, pp. 492–494, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Kauffmann and F. Demenais, “Gene-environment interactions in asthma and allergic diseases: challenges and perspectives,” The Journal of Allergy and Clinical Immunology, vol. 130, no. 6, pp. 1229–1240, 2012, quiz 1241-2. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Baos, D. Calzada, L. Cremades et al., “Biomarkers associated with disease severity in allergic and nonallergic asthma,” Molecular Immunology, vol. 82, pp. 34–45, 2017. View at Publisher · View at Google Scholar
  22. K. Tizaoui, W. Kaabachi, K. Hamzaoui, and A. Hamzaoui, “Association of single nucleotide polymorphisms in toll-like receptor genes with asthma risk: a systematic review and meta-analysis,” Allergy, Asthma & Immunology Research, vol. 7, no. 2, pp. 130–140, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Vercelli, “Genetic polymorphism in allergy and asthma,” Current Opinion in Immunology, vol. 15, no. 6, pp. 609–613, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Sampath, M. Adachi, S. Hatse et al., “Role of MRP4 and MRP5 in biology and chemotherapy,” AAPS PharmSci, vol. 4, no. 3, p. E14, 2002. View at Publisher · View at Google Scholar
  25. Y. Sassi, A. Abi-Gerges, J. Fauconnier et al., “Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes,” The FASEB Journal, vol. 26, no. 3, pp. 1009–1017, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Hamberg, P. Hedqvist, and K. Radegran, “Identification of 15-hydroxy-5,8,11,13-eicosatetraenoic acid (15-HETE) as a major metabolite of arachidonic acid in human lung,” Acta Physiologica Scandinavica, vol. 110, no. 2, pp. 219–221, 1980. View at Publisher · View at Google Scholar · View at Scopus
  27. A. James, K. Daham, L. Backman et al., “The influence of aspirin on release of eoxin C4, leukotriene C4 and 15-HETE, in eosinophilic granulocytes isolated from patients with asthma,” International Archives of Allergy and Immunology, vol. 162, no. 2, pp. 135–142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Feltenmark, N. Gautam, A. Brunnström et al., “Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 2, pp. 680–685, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. H. K. Trinh, S. C. Kim, K. Cho et al., “Exploration of the sphingolipid metabolite, sphingosine-1-phosphate and sphingosine, as novel biomarkers for aspirin-exacerbated respiratory disease,” Scientific Reports, vol. 6, Article ID 36599, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Roviezzo, B. D’Agostino, V. Brancaleone et al., “Systemic administration of sphingosine-1-phosphate increases bronchial hyperresponsiveness in the mouse,” American Journal of Respiratory Cell and Molecular Biology, vol. 42, no. 5, pp. 572–577, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Idzko, E. Panther, S. Corinti et al., “Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses,” The FASEB Journal, vol. 16, no. 6, pp. 625–627, 2002. View at Publisher · View at Google Scholar
  32. S. Palikhe, S. H. Kim, R. Y. Kim, E. M. Yang, and H. S. Park, “XXIV World Allergy Congress: Seoul, Korea,” The World Allergy Organization Journal, vol. 9, Supplement 1, pp. 14–17, 2016. View at Publisher · View at Google Scholar
  33. A. Y. Liu, H. Zheng, and G. Ouyang, “Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments,” Matrix Biology, vol. 37, pp. 150–156, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Li, P. Gao, Y. Zhi et al., “Periostin: its role in asthma and its potential as a diagnostic or therapeutic target,” Respiratory Research, vol. 16, no. 1, p. 57, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. J. K. Bentley, Q. Chen, J. Y. Hong et al., “Periostin is required for maximal airways inflammation and hyperresponsiveness in mice,” The Journal of Allergy and Clinical Immunology, vol. 134, no. 6, pp. 1433–1442, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Agrawal and R. G. Townley, “Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma,” Expert Opinion on Biological Therapy, vol. 14, no. 2, pp. 165–181, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Monteseirin, I. Bonilla, J. Camacho, J. Conde, and F. Sobrino, “Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: the effect of immunotherapy,” The Journal of Allergy and Clinical Immunology, vol. 107, no. 4, pp. 623–626, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Polonikov, M. Solodilova, and V. Ivanov, “Genetic variation of myeloperoxidase gene contributes to atopic asthma susceptibility: a preliminary association study in Russian population,” The Journal of Asthma, vol. 46, no. 5, pp. 523–528, 2009. View at Publisher · View at Google Scholar · View at Scopus